Comparative study to see the effect of magnesium sulphate as an agent to reduced pain when given via spinal anaesthesia or intravenous routes in patients for hip surgery.

A Comparative Study To Determine The Analgesic Efficacy Of Intravenous Magnesium Sulphate Versus Intrathecal Magnesium Sulphate As An Adjuvant To Bupivacaine In Patients Scheduled For Extracapsular Hip Fracture Surgeries Under Spinal Anaesthesia

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/06/005923

Enrollment

Registered

2015-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Extracapsular hip fracture patients

Interventions

Intervention1: intravenous drug versus intrathecal drug: magnesium sulphate is given through intravenous route as 50 mg/kg and intrathecal route as 50 mg as o.1 ml volume and compared with the contro

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical classIandII. BMI 18.5-39.9 Patients undergoing extracapsular hip surgeries under subarachnoid block

Exclusion criteria

Exclusion criteria: BMI > 40. Absolute contraindications for spinal anaesthesia. Uncontrolled and labile hypertension. Allergic to any of the study drugs. Patients refusal for spinal anaesthesia.

Design outcomes

Primary

Measure	Time frame
To compare the analgesic efficacy with magnesium sulphate using intravenous and intrathecal routes.Timepoint: To compare the analgesic efficacy with magnesium sulphate using intravenous and intrathecal routes.	—

Secondary

Measure	Time frame
To compare the haemodynamic stability in the form of non-invasive BP, Heart rate, SpO2 intraoperatively and post-operatively.Timepoint: Intra-operative monitoring at Base line and then every 1 min up to 10 min,then every 5 min upto 40 min, then every 10 min upto 60 min,then every 15 min upto 120 min,then every 30 min upto 360 min or till then the surgery over.o hour is taken as the time when the patient was shifted to recovery.The patient is followed at 0hr, 1hr,2hr,3hr,4hr,5hr,6hr,8hr,10 hr,12 hr, 15hr, 18 hr and 24 hr after the surgery.	—

Measure

Time frame

To compare the haemodynamic stability in the form of non-invasive BP, Heart rate, SpO2 intraoperatively and post-operatively.Timepoint: Intra-operative monitoring at Base line and then every 1 min up to 10 min,then every 5 min upto 40 min, then every 10 min upto 60 min,then every 15 min upto 120 min,then every 30 min upto 360 min or till then the surgery over.o hour is taken as the time when the patient was shifted to recovery.The patient is followed at 0hr, 1hr,2hr,3hr,4hr,5hr,6hr,8hr,10 hr,12 hr, 15hr, 18 hr and 24 hr after the surgery.

—

Countries

India

Contacts

Public ContactArvind kumar

DR.RPGMC .Tanda Kangra (H.P)

dineshkansal56@gmail.com9418454624

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026